<DOC>
	<DOCNO>NCT02625675</DOCNO>
	<brief_summary>The observational pilot study Churchill Hospital , fund Oxford Respiratory Trials Unit , assess feasibility efficacy thoracic ultrasound ( TUS ) assessment patient undergo talc pleurodesis via intercostal chest drain ( ICD ) recurrent symptomatic malignant pleural effusion ( MPE ) . Participants undergo TUS pre post pleurodesis four occasion . We hypothesise TUS score system able predict short long-term pleurodesis success earlier current conventional medical practice allows . This study may ultimately allow proposal treatment algorithm manage patient MPE efficient manner .</brief_summary>
	<brief_title>Using Thoracic Ultrasound Predict Pleurodesis Success Malignant Pleural Effusions : Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<criteria>The participant willing able give inform consent participation study . Adult male female , age 18 year . Diagnosed malignant pleural effusion require intercostal chest drain insertion subsequent talc slurry pleurodesis symptom relief and/or therapeutic purpose part routine clinical care . Age le 18 year . Inability provide informed consent Known hypersensitivity/allergy medical talc , contraindication administration intrapleural talc , determine responsible clinician . Evidence significant trap lung would prevent pleurodesis perform , determine clinician responsible assess patient . Expected survival less one month due underlie comorbidities .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>